Ivus-A 10/75 Capsule contains a combination of Rosuvastatin 10 mg and Aspirin 75 mg, formulated to manage cardiovascular risk factors effectively. Rosuvastatin is a potent statin that inhibits HMG-CoA reductase, the key enzyme in cholesterol biosynthesis, thereby significantly reducing low-density lipoprotein cholesterol (LDL-C) levels and improving lipid profiles. Aspirin, at a low dose of 75 mg, acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase-1 (COX-1), which reduces thromboxane A2 production and prevents platelet aggregation. This dual-action capsule is indicated for patients at high risk of atherosclerotic cardiovascular disease (ASCVD), including those with hyperlipidemia and a history of myocardial infarction, stroke, or other thrombotic events. Ivus-A 10/75 is utilized to lower the incidence of major cardiovascular events such as heart attacks and strokes by addressing both cholesterol levels and platelet activity. The combination therapy enhances patient compliance by reducing pill burden. It should be used under medical supervision, with monitoring of liver function, muscle symptoms, and bleeding risk. Contraindications include active bleeding, hypersensitivity to components, and severe liver disease. Appropriate lifestyle modifications should accompany pharmacotherapy for optimal outcomes.